Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

Zayo Group (ZAYO) Q4 Earnings and Revenues Beat Estimates

Tale of the Tape

Zayo Group (ZAYO) delivered earnings and revenue surprises of 73.33% and 0.52%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

ZAYO

Zacks Equity Research

Synlogic Discontinues Development of SYNB1020, Stock Down

Analyst Blog

Synlogic (SYBX) discontinues the development of its early-stage pipeline candidate, SYNB1020, for the treatment of hyperammonemia, following disappointing study results.

ABBV RHHBY ACOR SYBX

Zacks Equity Research

Franco-Nevada Up 2% Since Q2 Earnings Release: Here's Why

Analyst Blog

Franco-Nevada's (FNV) growth prospects look bright, backed by benefits from the Cobre Panama project and robust energy revenues.

FNV KGC AGI ARNC

Zacks Equity Research

Will McCormick Keep Dazzling on Strong Brands & Saving Plans?

Analyst Blog

McCormick (MKC) is on track with the CCI program to boost savings. Also, it focuses on new product development to augment market reach.

OLLI IPAR HSY MKC

Sejuti Banerjea

Tesla Feels the Heat as Walmart Sues

Analyst Blog

Walmart just sued Tesla over SolarCity manufactured and installed panels that resulted in rooftop fires at seven of its stores.

CRMT TSLA IPI FGP WMT CNSL

Tracey Ryniec

When "Insider" Greed Is Good

Weekend Wisdom

Not all insider buys are made equal. But when you focus on the right ones, the reward can be tremendous.

Zacks Equity Research

Here's Why You Should Add HEICO (HEI) Stock to Your Portfolio

Analyst Blog

HEICO (HEI) is a promising pick for investors, courtesy of these four factors.

HEI AJRD TDY TDG

Zacks Equity Research

Intel (INTC) Unveils Latest A.I. Chip, Springhill: Key Takeaways

Analyst Blog

Intel's (INTC) first AI-chip to facilitate companies having higher workloads with accelerated inference. Notably, Facebook is already utilizing the chip.

FB NVDA INTC XLNX

Zacks Equity Research

Reasons to Hold Grainger (GWW) in Your Portfolio for Now

Analyst Blog

Backed by upbeat outlook and long-term growth opportunities, Grainger (GWW) is worth retaining in the portfolio at the moment.

UNF AVY AIN GWW

Zacks Equity Research

Celanese (CE) Increases Prices of Ethyl Acetate in Europe

Analyst Blog

Celanese's (CE) latest hike in prices is incremental to any previously announced hikes.

CE AGI KGC ARNC

Zacks Equity Research

Western Digital's New Drives Offer Immersive Gaming Experience

Analyst Blog

Western Digital (WDC) launches five new high storage-capable gaming drives, featuring high-performance capabilities to provide users with immersive gaming experience.

STX WDC PRFT MSFT

Zacks Equity Research

Will Canada's Extended Oil Cut Plan Boost the Energy Sector?

Analyst Blog

With pipeline crisis in Canada not likely to resolve anytime soon, the oil curtailment program has been extended through 2020-end.

SU CVE ENB TRP

Zacks Equity Research

Endo Up on Settlement of a Few Cases Related to Opioid Drugs

Analyst Blog

Endo (ENDP) finally has some good news for investors with the settlement of a few cases in Ohio related to opioid medications.

AGN JNJ ENDP TEVA

Zacks Equity Research

Funko, ExxonMobil, JD.com, Home Depot and Lowe???s highlighted as Zacks Bull and Bear of the Day

Press Releases

Funko, ExxonMobil, JD.com, Home Depot and Lowe???s highlighted as Zacks Bull and Bear of the Day

HD LOW XOM FNKO

Zacks Equity Research

Quintana (QES) to Divest Pressure Pumping Assets, Cut Costs

Analyst Blog

Quintana Energy Services (QES) announces the layoff of nearly 10% of its workforce as a cost-reduction effort.

DRQ INT ENB QES

Zacks Equity Research

Assurant Surges 37% Year to Date: Will the Rally Continue?

Analyst Blog

Assurant's (AIZ) operational excellence and growth initiatives help the stock continue the bull run.

RDN JRVR AIZ MTG

Zacks Equity Research

Milacron (MCRN) Stock Rallies 33% YTD: What's Driving it?

Analyst Blog

Milacron (MCRN) is likely to offset the headwind from tariffs by focusing on pricing actions, negotiations with existing vendors and making supply chain modifications.

HI MCRN AVY AIN

Zacks Equity Research

NuCana Stops Patient Enrollment in Pancreatic Cancer Study

Analyst Blog

NuCana (NCNA) suspends patient enrollment in the phase III study on Acelarin, currently evaluated for treating patients with metastatic pancreatic cancer, who were unfit for combination chemotherapy.

LLY ALXN ALDR NCNA

Zacks Equity Research

Tandem Diabetes Rides on t:slim X2 Uptake, Product Pipeline

Analyst Blog

Robust domestic sales along with a strong unveiling of the t:slim X2 Insulin Pump in the international markets augur well for Tandem Diabetes (TNDM).

ABT TNDM BAX XRAY

Zacks Equity Research

Teva Launches Generic Version of Mylan's EpiPen for KIds

Analyst Blog

Teva (TEVA) launches generic version of Mylan's (MYL) popular EpiPen Jr allergy treatment at a price of $300 for a pack of two.

PFE NVS TEVA MYL

Zacks Equity Research

Biotech Stock Roundup: CELG's Inrebic Gets FDA Nod, SRPT Suffers Setback & More

Analyst Blog

Key highlights of the past week include drug approvals, and other regulatory and pipeline news.

SRPT REGN CELG VNDA NBRV VRTX GILD

Zacks Equity Research

FDA OKs Medtronic's Evolut TAVR New Indication for Low Risk

Analyst Blog

With the FDA's expanded indication nod, Medtronic's (MDT) Evolut TAVR platform now comes in handy for treating symptomatic severe aortic stenosis patients across all risk categories.

ABT BAX MDT XRAY

Zacks Equity Research

Synchrony Financial Up 40.4% YTD: Will the Rally Continue?

Analyst Blog

Synchrony Financial's (SYF) interest income and strategic initiatives should aid revenue growth. This will likely boost its share price further.

CATM PYPL SYF V

Zacks Equity Research

Analog Devices (ADI) Q3 Earnings & Revenues Top Estimates

Analyst Blog

Analog Devices' (ADI) strong momentum in communications market benefits fiscal third-quarter results. However, weak performance in industrial, consumer and automotive markets remains a headwind.

RNG LOGM GRMN ADI

Zacks Equity Research

Here's Why Hold Strategy is Apt for Werner (WERN) Stock Now

Analyst Blog

Werner's (WERN) cost-containment and fleet upgrade efforts bode well for the company.

CNI CP MRTN WERN

Zacks Equity Research

What's in the Cards for Hewlett Packard (HPE) Q3 Earnings?

Analyst Blog

Hewlett Packard's (HPE) Q3 fiscal 2019 results are likely to benefit from the growing momentum in Value Compute portfolio. However, a fall in the tier-1 server shipments is a downside.

HPE AMZN MSFT CARE

Zacks Equity Research

AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study

Analyst Blog

AstraZeneca's (AZN) Imfinzi fails to improve overall survival in a study for previously treated stage IV non-small cell lung cancer (NSCLC) patients.

BMY MRK PFE AZN

Zacks Equity Research

Amazon Targets Subscribers in Australia With Original Content

Analyst Blog

Amazon's (AMZN) contract with Rebel Wilson to make its first Australian original series is likely to expand its presence in the streaming market of Australia.

DIS AMZN NFLX AAPL

Zacks Equity Research

Company News For Aug 21, 2019

Corporate Summary

Companies in the news are: KSS, MDT, BIDU and SRPT

BIDU MDT SRPT KSS

Aniruddha Ganguly

Scientific Instruments Industry Outlook: Prospects Look Good

Industry Outlook

The Zacks Instruments - Scientific industry is benefiting from solid prospects in emerging markets, robust end-market demand and increasing spending on health care.

WAT PKI MTD